Cite
[Clinical contribution on the use of 6-alpha-methyl-17-alpha-acetoxyprogesterone as an ovariostatic]
MLA
S, Pedronetto, and Zema V. “[Clinical Contribution on the Use of 6-Alpha-Methyl-17-Alpha-Acetoxyprogesterone as an Ovariostatic].” Minerva Ginecologica, vol. 21, no. 13, July 1969. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........339f0c0cbc0b02da8d522d231083df2b&authtype=sso&custid=ns315887.
APA
S, P., & V, Z. (1969). [Clinical contribution on the use of 6-alpha-methyl-17-alpha-acetoxyprogesterone as an ovariostatic]. Minerva Ginecologica, 21(13).
Chicago
S, Pedronetto, and Zema V. 1969. “[Clinical Contribution on the Use of 6-Alpha-Methyl-17-Alpha-Acetoxyprogesterone as an Ovariostatic].” Minerva Ginecologica 21 (13). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........339f0c0cbc0b02da8d522d231083df2b&authtype=sso&custid=ns315887.